Fecal Microbiota Transplantation and Analysis of Fecal Microbiome in IBD Patients

  • End date
    Dec 31, 2023
  • participants needed
  • sponsor
    Yonsei University
Updated on 22 January 2021
ulcerative colitis
crohn's disease
fecal microbiota transplantation


Fecal microbiome of donor and recipient will be analyzed before and after fecal microbiota transplantation in IBD patients.


Fecal microbiota transplantation will be performed to the IBD patients, and microbial analysis will be done for donor and recipient feces. Fecal microbiota transplantation will be done twice via colonoscopy, with one month of duration. During the early stage of Fecal microbiota transplantation, recipient feces will be analyzed for the intestinal microbiota frequently.

Clinical outcome will be assessed 1month, 2month, 6month, and 1 year after the transplantation.

Relevance of intestinal microbial change and clinical outcome after transplantation and factors associated with successful clinical outcome will be investigated.

Condition Gastroenteritis, Gastroenteritis, Intestinal Diseases, Bowel Dysfunction, Inflammatory bowel disease, Inflammatory bowel disease, Bowel Dysfunction, inflammatory bowel diseases
Treatment Fecal microbiome transplantation
Clinical Study IdentifierNCT03399188
SponsorYonsei University
Last Modified on22 January 2021


Yes No Not Sure

Inclusion Criteria

years old to 80 years old at start of trial
Inflammatory bowel disease such as ulcerative colitis, Crohn's disease, and Behcet's colitis
Patients who do not respond to the conventional treatments or who do not wish/not able to use one
Patients who agree to participate in the trial after thorough explanation
Evidence of active disease

Exclusion Criteria

Patients whose CRP<8, calprotectin<200, and mucosal healing endoscopically (who are in stable state)
Patients whose symptom is due to other disease than IBD
_Patients with immunosuppressive disease
Patients who are clinically unstable such as massive hemorrhage or perforation
Patients with toxic megacolon, paralytic ileus, or symptomatic intestinal obstruction
Absolute neutrophil count (ANC) <1.5 10^9/L (1500/mm3)
Pregnant or under breast feeding
Patients enrolled in other clinical trials
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note